Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garratty

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
Vox Sanguinis|March 1, 2003
A new antigen of the Er collectionF Arriaga, A Mueller, K Rodberg, et al.
Retrovirology|June 1, 2004
Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort studyJennie R Orland, Baoguang Wang, David J Wright, et al.
Vox Sanguinis|February 22, 2005
First year donation patterns predict long-term commitment for first-time donorsG B Schreiber, U K Sharma, D J Wright, et al.
Transfusion|October 29, 2008
Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboonsRaymond P Goodrich, Krishna K Murthy, Suzann K Doane, et al.
Transfusion|November 17, 2007
Factors influencing donor returnKaren S Schlumpf, Simone A Glynn, George B Schreiber, et al.
Transfusion|September 1, 1992
Selection of platelets for refractory patients by HLA matching and prospective crossmatchingG Moroff, G Garratty, J M Heal, et al.
Transfusion|January 3, 2001
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificityL D Petz, G Garratty, L Calhoun, et al.
Blood|August 30, 2008
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionMelissa T Bartman, Zhanna Kaidarova, Dale Hirschkorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2010
Increased all-cause and cancer mortality in HTLV-II infectionHope H Biswas, Zhanna Kaidarova, George Garratty, et al.
JAMA|February 28, 1996
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral loadR E Dickover, E M Garratty, S A Herman, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Vox Sanguinis|March 1, 2003
A new antigen of the Er collectionF Arriaga, A Mueller, K Rodberg, et al.
Retrovirology|June 1, 2004
Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort studyJennie R Orland, Baoguang Wang, David J Wright, et al.
Vox Sanguinis|February 22, 2005
First year donation patterns predict long-term commitment for first-time donorsG B Schreiber, U K Sharma, D J Wright, et al.
Transfusion|October 29, 2008
Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboonsRaymond P Goodrich, Krishna K Murthy, Suzann K Doane, et al.
Transfusion|November 17, 2007
Factors influencing donor returnKaren S Schlumpf, Simone A Glynn, George B Schreiber, et al.
Transfusion|September 1, 1992
Selection of platelets for refractory patients by HLA matching and prospective crossmatchingG Moroff, G Garratty, J M Heal, et al.
Transfusion|January 3, 2001
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificityL D Petz, G Garratty, L Calhoun, et al.
Blood|August 30, 2008
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionMelissa T Bartman, Zhanna Kaidarova, Dale Hirschkorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2010
Increased all-cause and cancer mortality in HTLV-II infectionHope H Biswas, Zhanna Kaidarova, George Garratty, et al.
JAMA|February 28, 1996
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral loadR E Dickover, E M Garratty, S A Herman, et al.
Pageof 27